Skip to content
Screener

Tyra Biosciences, Inc. TYRA Other Non-Current Assets

Other Non-Current Assets at other companies

Incyte logo
IncyteINCY
$86.76M+167%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$338.14M+35.7%
UroGen Pharma logo
UroGen PharmaURGN
$8.76M+994%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.12M+11.1%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$156K-11.4%
Kura Oncology logo
Kura OncologyKURA
$13.99M+54.1%

Other financials

Income statement

See full
Operating income-$42.0M-31.9%
Net income-$39.3M-39.6%
EPS (diluted)-$0.64-36.2%

Balance sheet

See full
Cash & equivalents$85.0M-15.7%
Total debt$5.7M-6.9%
Total equity$387.6M+19.8%
Total assets$412.0M+20.0%

Cash flow

See full
Operating cash flow-$32.6M-27.9%
CapEx$88.0K+529%
Free cash flow-$32.7M-28.2%

Valuation

See full
Market cap$1.58B+195%
Enterprise value$1.5B+238%

Returns & leverage

See full
Return on equity-36.9%+21.1pp
Debt / equity0.0×
Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 8:03 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-220645
Line itemMarch 31, 2026December 31, 2025
Restricted cash8841,000
Property and equipment, net1,2151,314
Right-of-use assets5,4435,573
Other long-term assets9,8859,272
Total assets$412,040$282,609
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$3,642$1,178

Item 1. Condensed Financial Statements

FAQ

What is Tyra Biosciences, Inc.'s other non-current assets?
Tyra Biosciences, Inc. (TYRA) reported other non-current assets of $9.89M in Q1 2026.
How has Tyra Biosciences, Inc.'s other non-current assets changed year-over-year?
Tyra Biosciences, Inc.'s other non-current assets decreased by 5.3% year-over-year, from $10.44M to $9.89M.
What is the long-term trend for Tyra Biosciences, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s other non-current assets has grown at a 238.1% compound annual growth rate (CAGR), from $21K to $9.27M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Tyra Biosciences, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude